Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2765243 | Journal of Critical Care | 2008 | 9 Pages |
Abstract
A customizable decision model using patient-specific inputs can be used to inform the treatment decision when considering the use of drotrecogin α (activated) therapy by weighing the risks vs the benefits of therapy in the treatment of severe sepsis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Daniel P. MD, MSc, Anthony C. PhD, Richard W. DrPH, Joseph A. MD, MSc, Mark H. MD, MS,